Airain Ltd’s Oruka Therapeutics ORKA Stock Holding History

Airain Ltd’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-8	Closed	-$22K	–	963
2014 Q1	$22K	Buy	+8	New	+$23.4K	﹤0.01%	684

Other funds holding ORKA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Airain Ltd's ORKA Position: Q2 2014 in Review

Airain Ltd sold out of Oruka Therapeutics (ORKA) in Q2 2014, closing a stake of 8 shares — an estimated $22K sold.

Airain Ltd first reported a position in ORKA in Q1 2014 and held it in 1 quarter. The position peaked at $22K in Q1 2014. 14 funds tracked by Wall St. Rank hold ORKA as of Q2 2014.

Airain Ltd reported no remaining Oruka Therapeutics position as of Q2 2014 after selling out during the quarter.
Airain Ltd sold 8 Oruka Therapeutics shares in Q2 2014, an estimated $22K.
Airain Ltd first reported a position in Oruka Therapeutics in Q1 2014 and held it in 1 quarter.
Airain Ltd's Oruka Therapeutics position peaked at $22K in Q1 2014.
14 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2014.

Based on Airain Ltd's 13F filing for Q2 2014, filed 5 Aug 2014.